Tue, Jul 22, 2014, 4:05 AM EDT - U.S. Markets open in 5 hrs 25 mins


% | $
Click the to save as a favorite.

POZEN Inc. Message Board

  • eu9mec eu9mec Sep 7, 2011 3:54 PM Flag

    Plachetka presented

    I just listened in to the Stifel presentation. CEO presented today. It was a very good presentation regarding the lawsuit and PA. I wish he would have spent more time talking about how undervalued the stock is at 2.75.

    I am more optimistic about PA doing well once it's launched, compared to Vimovo. It seems that some of the headwinds on Vimovo is based on price. PA on the other hand won't be priced so high, about $1 compared to $.60 for buying individually. I've got to think that vast majority of doctors will prescribe PA vs separately. It's a pretty big market potential. I'd say they can achieve $250M per year in revs.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'm looking forward to the heart conference in Nov for that data and he said top line data on the PA swtudies by Q2. I think the lower amount of immediate release omeprazole rather than an enteric coating is attractive but I thought he previously said that they are now looking into the PPI's affect on the heart similar to PERVACID's affect on PLAVIX

8.07-0.08(-0.98%)Jul 21 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Netflix, Inc.
NasdaqGSMon, Jul 21, 2014 4:00 PM EDT